Phase 2 Gastric Adenocarcinoma trials recruiting now

All Gastric Adenocarcinoma trials, every phase

Other phases for Gastric Adenocarcinoma

Phase 2 Gastric Adenocarcinoma trials

• A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers
  NCT06422403 · Phase: Phase 2 · Ages: 21 Years to 99 Years · Sex: All (male and female) · 1 location
• Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
  NCT04114136 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI
  NCT06333314 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 44 locations
• Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
  NCT07529808 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels
  NCT07282912 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.